New York, NY -- (SBWIRE) -- 12/27/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Cincinnati Bell Inc (NYSE:CBB), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Sequenom, Inc (NASDAQ:SQNM), Gafisa SA (ADR) (NYSE:GFA)
Cincinnati Bell Inc (NYSE:CBB) showed a volume of 1.11 million shares by the end of last trade whereas the average volume of the stock remained 1.29million shares. The stock opened the session at $3.51 but then moved to 3.57. At that price, the stock showed a positive performance of 1.71%. Cincinnati Bell Inc is a full-service provider of data and voice communications services over wireline and wireless networks, a full-service provider of data center colocation and related managed services, and a reseller of information technology (IT) and telephony equipment. The Company provides telecommunications service to businesses and consumers in the Greater Cincinnati and Dayton areas on its owned wireline and wireless networks. The Company also provides business customers with outsourced data center colocation operations and related managed services in data center facilities,
Will CBB Continue To Move Higher? Find Out Here
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) opened the session at $3.33 and closed the session at $3.29. The stock showed a negative performance of -1.20% in previous trading session. Traded with volume of 1.09 million shares in the prior session and the average volume of the stock remained 3.06 million shares. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10% cream, sold in the United States and Canada as Abreva by its marketing partner GlaxoSmithKline Consumer Healthcare,
Has AVNR Found The Bottom And Ready To Gain Momentum? Find Out Here
Sequenom, Inc (NASDAQ:SQNM) opened the session at $2.26 and closed the session at $2.29. The stock showed a positive performance of 1.33% in previous trading session. Traded with volume of 1.08 million shares in the prior session and the average volume of the stock remained 2.29 million shares. The beta of the stock remained 0.40. Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company committed to providing molecular diagnostic testing services, and research use only products, services, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural,
Why Should Investors Buy SQNM After The Recent Gain? Just Go Here and Find Out
Gafisa SA (ADR) (NYSE:GFA) the stock advanced 0.30% and finished the session at $3.31. Traded with volume of 1.06 million shares in the prior session and the average volume of the stock remained 1.56 million shares. The beta of the stock remained 2.55. Gafisa SA is a Brazil-based company engaged in the homebuilding and real estate operations. The Company is involved in the promotion, administration, purchase, sale and trade of real estate properties; provision of financing services to real estate customers; construction and provision of civil engineering services, and development and implementation of marketing strategies related to its own or third party real estate projects. The Company divides its business into three segments: Gafisa,
Will GFA Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)